Lu-TARGO (177Lu-TARGeted Osteosarcoma Therapy)

Clinical trial NCT07357519 · RECRUITING

Trial details

NCT number: NCT07357519
Sponsor: Lantheus Medical Imaging
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Relapsed / Refractory Osteosarcoma

Start date: 2026-02-03
Primary completion: 2027-08-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.